|
|
Exemptions from the restrictions on the sale and supply of prescription only medicines
|
|
Column 1
|
Column 2
|
Column 3
|
Column 4
|
Column 5
|
|
Substance
|
Maximum strength
|
Route of
administration,
use or
pharmaceutical
form
|
Treatment limitations
|
Maximum quantity
|
|
Atropine |
|
(1) Internal |
|
|
|
|
|
(a) by inhaler |
|
|
|
|
|
(b) otherwise than by inhaler |
(b) 300mcg (MD) |
|
|
|
|
|
1mg (MDD) |
|
|
|
|
(2) External (except ophthalmic) |
|
|
|
Atropine Methobromide |
|
(1) Internal |
|
|
|
|
|
(a) by inhaler |
|
|
|
|
|
(b) otherwise than by inhaler |
(b) 400mcg (MD) |
|
|
|
|
|
1.3mg (MDD) |
|
|
|
|
(2) External (except ophthalmic) |
|
|
|
Atropine Methonitrate |
|
Internal |
|
|
|
|
|
(a) by inhaler |
|
|
|
|
|
(b) otherwise than by inhaler |
(b) 400mcg (MD) |
|
|
|
|
|
1.3mg (MDD) |
Atropine Oxide Hydrochloride |
|
|
|
(1) Internal |
|
|
|
|
|
(a) by inhaler |
|
|
|
|
|
(b) otherwise than by inhaler |
(b) 360mcg (MD) |
|
|
|
|
|
1.2mg (MDD) 3 |
|
|
|
|
(2) External (except ophthalmic) |
|
|
|
Atropine Sulphate |
|
(1) Internal |
|
|
|
|
|
(a) by inhaler |
|
|
|
|
|
(b) otherwise than by inhaler |
(b) 360mcg (MD) |
|
|
|
|
|
1.2mg (MDD) |
|
|
|
|
(2) External (except ophthalmic) |
|
|
|
Auranofin |
|
|
|
|
|
Azapropazone |
|
|
|
|
|
Azathioprine |
|
|
|
|
|
Azathioprine Sodium |
|
|
|
|
|
Azelaic Acid |
|
|
|
|
|
Azelastine Hydrochloride |
|
For nasal administration |
140mcg per nostril (MD) |
Container or package containing not more than 5,040mcg of Azelastine Hydrochloride |
|
|
|
For the treatment of seasonal allergic rhinitis |
280mcg per nostril (MDD) |
|
|
|
|
For use in adults and children not less than 12 years |
|
|
|
|
|
As a non-aerosol, aqueous form |
|
|
|
Azidocillin Potassium |
|
|
|
|
|
Azithromycin |
|
|
|
|
|
Azlocillin Sodium |
|
|
|
|
|
Aztreonam |
|
|
|
|
|
Bacampicillin Hydrochloride |
|
|
|
|
|
Bacitracin |
|
|
|
|
|
Bacitracin Methylene Disalicylate |
|
|
|
|
|
Bacitracin Zinc |
|
|
|
|
|
Baclofen |
|
|
|
|
|
Bambuterol Hydrochloride |
|
|
|
|
|
Barium Carbonate |
|
|
|
|
|
Barium Chloride |
|
|
|
|
|
Barium Sulphide |
|
|
|
|
|
Beclamide |
|
|
|
|
|
Beclomethasone |
|
|
|
|
|
Beclomethasone Dipropionate |
|
For nasal administration (non-aerosol) |
100mcg per nostril (MD) |
Container or package containing not more than 5,600mcg of Beclomethasone Dipropionate |
|
|
|
|
200mcg per nostril (MDD) |
|
|
|
|
For the prevention and treatment of allergic rhinitis |
|
|
|
|
|
For use in adults and children not less than 12 years |
|
|
|
Belladonna Herb |
|
(1) Internal |
(1) 1mg of the alkaloids (MDD) |
|
|
|
|
(2) External |
|
|
|
Belladonna Root |
|
(1) Internal |
(1) 1mg of the alkaloids (MDD) |
|
|
|
|
(2) External |
|
|
|
Bemegride |
|
|
|
|
|
Bemegride Sodium |
|
|
|
|
|
Benapryzine Hydrochloride |
|
|
|
|
|
Bendrofluazide |
|
|
|
|
|
Benethamine Penicillin |
|
|
|
|
|
Benoxaprofen |
|
|
|
|
|
Benperidol |
|
|
|
|
|
Benserazide Hydrochloride |
|
|
|
|
|
Bentiromide |
|
|
|
|
|
Benzathine Penicillin |
|
|
|
|
|
Benzbromarone |
|
|
|
|
|
Benzhexol Hydrochloride |
|
|
|
|
|
Benzilonium Bromide |
|
|
|
|
|
Benzocaine |
|
Any use except ophthalmic use |
|
|
|
Benzoctamine Hydrochloride |
|
|
|
|
Other UK SIs |
Home |
National Assembly for Wales Statutory Instruments |
Scottish Statutory Instruments |
Statutory Rules of Northern Ireland |
Her Majesty's Stationery Office